drugset / Trial / NCT05588804

Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections

NCT05588804

Phase 3 Completed 556 enrolled Sandoz
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will evaluate the efficacy and safety of Broncho-munal®, capsules, 7 mg (Sandoz dd, Slovenia) versus Placebo in the treatment of patients with acute uncomplicated respiratory tract infections.

Timeline

Start
2022-11-07
Primary completion
2022-12-18
Completion
2022-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Broncho-Vaxom Other / unclassified 7 mg